13F HOLDINGS REPORT
Euclidean Capital LLC
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001012975-24-000215
Total Value
$780.0M
Positions
13
Other Managers
0
Confidential Omitted
No
Holdings (13)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR S&P 500 ETF TR | SPY | 974,641 | $509.8M | 65.36% |
| 2 | ISHARES TR | 46429B598 | 2,425,144 | $125.1M | 16.04% |
| 3 | SPDR GOLD TR | GLD | 432,271 | $88.9M | 11.40% |
| 4 | ORIC PHARMACEUTICALS INC | ORIC | 989,410 | $13.6M | 1.74% |
| 5 | FOGHORN THERAPEUTICS INC | FHTX | 1,573,761 | $10.6M | 1.35% |
| 6 | ALECTOR INC | ALEC | 1,307,858 | $7.9M | 1.01% |
| 7 | RAPT THERAPEUTICS INC | 75382E109 | 657,899 | $5.9M | 0.76% |
| 8 | 23ANDME HOLDING CO | 90138Q108 | 10,243,122 | $5.4M | 0.70% |
| 9 | TENAYA THERAPEUTICS INC | TNYA | 1,015,705 | $5.3M | 0.68% |
| 10 | PMV PHARMACEUTICALS INC | PMVP | 2,627,643 | $4.5M | 0.57% |
| 11 | NGM BIOPHARMACEUTICALS INC | 62921N105 | 992,168 | $1.6M | 0.20% |
| 12 | SURROZEN INC | SRZNW | 87,696 | $1.4M | 0.18% |
| 13 | SURROZEN INC | SRZNW | 170,833 | $5,159 | 0.00% |